PET Study With [89Zr]-Df-CriPec® Docetaxel
Clinical trial NCT03712423 · COMPLETED
Trial details
- NCT number
- NCT03712423
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-01
- Primary completion
- 2020-03-25
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.